Skip to content
SentinelMarket desk
Switch to dark mode

지니너스

389030KOSDAQView the 바이오 R&D sectorTheme Bio & healthcare

1,580KRWMarket close of 10/20 (Tue)

Down -6.51%-110KRWMarket close of 10/20 (Tue)

Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/21 (Wed)1,579KRWDown -0.06%

Preliminary · just after the close · replaced by official KRX data tomorrow morning

Open
1,699
High
1,699
Low
1,565
Day range
Day range low 1,565 high 1,699, open 1,699, close 1,580, previous close 1,690
Volume
43×10K shares
690.09 million KRW 1.21× the 20-session average

Market close of 10/20 (Tue)

Where it sits in the 1-year range

1-year close range 1,575 to 6,270 won, 0% up from the low

0% of the way up from the lowest close in 1 year (252 sessions) · -74.8% from the high

Something to check

1 to check: operating loss

Free · no sign-inSource from 2021-05-17

Points to check

  • Earningsto check-11.3B KRWOperating income over the last four quarters -11.3B KRW (loss)Operating income, 8 quarters
  • Recent filingsnot verifiedOutside filing data coverage, so not verified
  • Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified

The other 3 are within the usual range

  • Daily move-6.51%usual range
  • Trading value1.2×usual range
  • Data date10/20 (Tue)Market close
See the full check report

Quarterly results · Q1 2026

Source: DART financials (Q4 derived as annual − three quarters) · Amended filing reflected
  • Revenue2.4B KRWRevenue bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    -9.2%
    vs. prior quarter
    -23.9%
  • Operating income-2.0B KRWOperating income bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    Still a loss
    vs. prior quarter
    Still a loss
  • Operating margin-85.8%Operating margin bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    +4.8 pp
    vs. prior quarter
    +8.5 pp

Quarterly operating income trend

As of the latest official close · 2026-10-20Valuation filing date · 2026-05-15
2023Q3 -2.7B KRW2026Q1 -2.0B KRWQ4 values are derived as the annual figure minus Q1–Q3. The value table marks them in the Type column.

Same sector · 바이오 R&D

Down -2.19%

· 16 of 64 stocks up, preferred shares excluded · trading value 190.5B KRW

Same sector · top by trading value
Stock20DChangeTrading value
알테오젠Close over the last 20 sessions -9.6%Down -3.35%51.1B KRW
올릭스Close over the last 20 sessions -12.2%Down -4.03%19.1B KRW
디앤디파마텍Close over the last 20 sessions -11.8%Down -1.93%15.1B KRW
리가켐바이오Close over the last 20 sessions -15.4%Down -1.41%12.1B KRW
프로티나Close over the last 20 sessions +31.8%Up +7.38%10.0B KRW

Schedule

  • Next data 10/22 (Thu) after 08:50

Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 81% of trading value, about 92% of market capitalisation. Coverage status →

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.